nodes	percent_of_prediction	percent_of_DWPC	metapath
Doxepin—CYP2C19—Cyclosporine—focal segmental glomerulosclerosis	0.118	0.258	CbGbCtD
Doxepin—CYP2C9—Cyclosporine—focal segmental glomerulosclerosis	0.0979	0.214	CbGbCtD
Doxepin—ABCB1—Cyclosporine—focal segmental glomerulosclerosis	0.0951	0.208	CbGbCtD
Doxepin—CYP2D6—Cyclosporine—focal segmental glomerulosclerosis	0.0896	0.196	CbGbCtD
Doxepin—CYP3A4—Cyclosporine—focal segmental glomerulosclerosis	0.057	0.125	CbGbCtD
Doxepin—Fracture—Cyclosporine—focal segmental glomerulosclerosis	0.00777	0.0234	CcSEcCtD
Doxepin—Multiple fractures—Cyclosporine—focal segmental glomerulosclerosis	0.00777	0.0234	CcSEcCtD
Doxepin—Cerebration impaired—Cyclosporine—focal segmental glomerulosclerosis	0.00768	0.0231	CcSEcCtD
Doxepin—Polyp—Cyclosporine—focal segmental glomerulosclerosis	0.00742	0.0224	CcSEcCtD
Doxepin—Folliculitis—Cyclosporine—focal segmental glomerulosclerosis	0.00718	0.0217	CcSEcCtD
Doxepin—Cyst—Cyclosporine—focal segmental glomerulosclerosis	0.00675	0.0204	CcSEcCtD
Doxepin—Herpes zoster—Cyclosporine—focal segmental glomerulosclerosis	0.00599	0.0181	CcSEcCtD
Doxepin—Fungal infection—Cyclosporine—focal segmental glomerulosclerosis	0.00585	0.0176	CcSEcCtD
Doxepin—Tingling sensation—Cyclosporine—focal segmental glomerulosclerosis	0.00561	0.0169	CcSEcCtD
Doxepin—Stinging—Cyclosporine—focal segmental glomerulosclerosis	0.00557	0.0168	CcSEcCtD
Doxepin—Disturbance in attention—Cyclosporine—focal segmental glomerulosclerosis	0.00521	0.0157	CcSEcCtD
Doxepin—Viral infection—Cyclosporine—focal segmental glomerulosclerosis	0.005	0.0151	CcSEcCtD
Doxepin—Hyperbilirubinaemia—Cyclosporine—focal segmental glomerulosclerosis	0.00496	0.015	CcSEcCtD
Doxepin—Dysmenorrhoea—Cyclosporine—focal segmental glomerulosclerosis	0.00496	0.015	CcSEcCtD
Doxepin—Lacrimation increased—Cyclosporine—focal segmental glomerulosclerosis	0.0049	0.0148	CcSEcCtD
Doxepin—Nocturia—Cyclosporine—focal segmental glomerulosclerosis	0.00487	0.0147	CcSEcCtD
Doxepin—Hearing impaired—Cyclosporine—focal segmental glomerulosclerosis	0.00474	0.0143	CcSEcCtD
Doxepin—Hyperkalaemia—Cyclosporine—focal segmental glomerulosclerosis	0.00443	0.0134	CcSEcCtD
Doxepin—Nightmare—Cyclosporine—focal segmental glomerulosclerosis	0.00436	0.0131	CcSEcCtD
Doxepin—Neoplasm—Cyclosporine—focal segmental glomerulosclerosis	0.00408	0.0123	CcSEcCtD
Doxepin—Gynaecomastia—Cyclosporine—focal segmental glomerulosclerosis	0.00404	0.0122	CcSEcCtD
Doxepin—Mental disability—Cyclosporine—focal segmental glomerulosclerosis	0.00392	0.0118	CcSEcCtD
Doxepin—Gastroenteritis—Cyclosporine—focal segmental glomerulosclerosis	0.0037	0.0111	CcSEcCtD
Doxepin—Deafness—Cyclosporine—focal segmental glomerulosclerosis	0.00366	0.011	CcSEcCtD
Doxepin—Disorientation—Cyclosporine—focal segmental glomerulosclerosis	0.00366	0.011	CcSEcCtD
Doxepin—Vascular purpura—Cyclosporine—focal segmental glomerulosclerosis	0.00366	0.011	CcSEcCtD
Doxepin—Eczema—Cyclosporine—focal segmental glomerulosclerosis	0.00365	0.011	CcSEcCtD
Doxepin—Eye pain—Cyclosporine—focal segmental glomerulosclerosis	0.00363	0.0109	CcSEcCtD
Doxepin—Libido decreased—Cyclosporine—focal segmental glomerulosclerosis	0.00353	0.0107	CcSEcCtD
Doxepin—Hot flush—Cyclosporine—focal segmental glomerulosclerosis	0.0035	0.0106	CcSEcCtD
Doxepin—Increased appetite—Cyclosporine—focal segmental glomerulosclerosis	0.00349	0.0105	CcSEcCtD
Doxepin—Menopausal symptoms—Cyclosporine—focal segmental glomerulosclerosis	0.00347	0.0105	CcSEcCtD
Doxepin—Purpura—Cyclosporine—focal segmental glomerulosclerosis	0.0034	0.0103	CcSEcCtD
Doxepin—Lethargy—Cyclosporine—focal segmental glomerulosclerosis	0.00334	0.0101	CcSEcCtD
Doxepin—Disturbance in sexual arousal—Cyclosporine—focal segmental glomerulosclerosis	0.00325	0.0098	CcSEcCtD
Doxepin—Migraine—Cyclosporine—focal segmental glomerulosclerosis	0.00322	0.00972	CcSEcCtD
Doxepin—Breast disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00296	0.00893	CcSEcCtD
Doxepin—Cramp muscle—Cyclosporine—focal segmental glomerulosclerosis	0.00295	0.0089	CcSEcCtD
Doxepin—Bronchitis—Cyclosporine—focal segmental glomerulosclerosis	0.00272	0.00821	CcSEcCtD
Doxepin—Dysuria—Cyclosporine—focal segmental glomerulosclerosis	0.00265	0.00798	CcSEcCtD
Doxepin—Upper respiratory tract infection—Cyclosporine—focal segmental glomerulosclerosis	0.00263	0.00794	CcSEcCtD
Doxepin—Pollakiuria—Cyclosporine—focal segmental glomerulosclerosis	0.00262	0.00789	CcSEcCtD
Doxepin—Weight increased—Cyclosporine—focal segmental glomerulosclerosis	0.00258	0.00777	CcSEcCtD
Doxepin—Pneumonia—Cyclosporine—focal segmental glomerulosclerosis	0.00254	0.00766	CcSEcCtD
Doxepin—Infestation—Cyclosporine—focal segmental glomerulosclerosis	0.00252	0.00761	CcSEcCtD
Doxepin—Infestation NOS—Cyclosporine—focal segmental glomerulosclerosis	0.00252	0.00761	CcSEcCtD
Doxepin—Neuropathy peripheral—Cyclosporine—focal segmental glomerulosclerosis	0.00247	0.00746	CcSEcCtD
Doxepin—Stomatitis—Cyclosporine—focal segmental glomerulosclerosis	0.00246	0.00742	CcSEcCtD
Doxepin—Jaundice—Cyclosporine—focal segmental glomerulosclerosis	0.00246	0.00742	CcSEcCtD
Doxepin—Urinary tract infection—Cyclosporine—focal segmental glomerulosclerosis	0.00245	0.0074	CcSEcCtD
Doxepin—Hepatobiliary disease—Cyclosporine—focal segmental glomerulosclerosis	0.00239	0.0072	CcSEcCtD
Doxepin—Sinusitis—Cyclosporine—focal segmental glomerulosclerosis	0.00237	0.00714	CcSEcCtD
Doxepin—Hepatitis—Cyclosporine—focal segmental glomerulosclerosis	0.00227	0.00683	CcSEcCtD
Doxepin—Hypoaesthesia—Cyclosporine—focal segmental glomerulosclerosis	0.00226	0.0068	CcSEcCtD
Doxepin—Pharyngitis—Cyclosporine—focal segmental glomerulosclerosis	0.00225	0.00678	CcSEcCtD
Doxepin—Urinary tract disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00224	0.00675	CcSEcCtD
Doxepin—Connective tissue disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00223	0.00672	CcSEcCtD
Doxepin—Urethral disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00222	0.0067	CcSEcCtD
Doxepin—Tinnitus—Cyclosporine—focal segmental glomerulosclerosis	0.00211	0.00637	CcSEcCtD
Doxepin—Flushing—Cyclosporine—focal segmental glomerulosclerosis	0.0021	0.00634	CcSEcCtD
Doxepin—Angiopathy—Cyclosporine—focal segmental glomerulosclerosis	0.00206	0.0062	CcSEcCtD
Doxepin—Mediastinal disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00204	0.00616	CcSEcCtD
Doxepin—Chills—Cyclosporine—focal segmental glomerulosclerosis	0.00203	0.00613	CcSEcCtD
Doxepin—Arrhythmia—Cyclosporine—focal segmental glomerulosclerosis	0.00202	0.00611	CcSEcCtD
Doxepin—Alopecia—Cyclosporine—focal segmental glomerulosclerosis	0.002	0.00604	CcSEcCtD
Doxepin—Mental disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00199	0.00599	CcSEcCtD
Doxepin—Malnutrition—Cyclosporine—focal segmental glomerulosclerosis	0.00197	0.00595	CcSEcCtD
Doxepin—Flatulence—Cyclosporine—focal segmental glomerulosclerosis	0.00194	0.00586	CcSEcCtD
Doxepin—Tension—Cyclosporine—focal segmental glomerulosclerosis	0.00194	0.00584	CcSEcCtD
Doxepin—Dysgeusia—Cyclosporine—focal segmental glomerulosclerosis	0.00193	0.00583	CcSEcCtD
Doxepin—Nervousness—Cyclosporine—focal segmental glomerulosclerosis	0.00192	0.00578	CcSEcCtD
Doxepin—Muscle spasms—Cyclosporine—focal segmental glomerulosclerosis	0.0019	0.00572	CcSEcCtD
Doxepin—Vision blurred—Cyclosporine—focal segmental glomerulosclerosis	0.00186	0.00561	CcSEcCtD
Doxepin—Tremor—Cyclosporine—focal segmental glomerulosclerosis	0.00185	0.00557	CcSEcCtD
Doxepin—Ill-defined disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00183	0.00552	CcSEcCtD
Doxepin—Anaemia—Cyclosporine—focal segmental glomerulosclerosis	0.00182	0.0055	CcSEcCtD
Doxepin—Agitation—Cyclosporine—focal segmental glomerulosclerosis	0.00181	0.00547	CcSEcCtD
Doxepin—Malaise—Cyclosporine—focal segmental glomerulosclerosis	0.00178	0.00537	CcSEcCtD
Doxepin—Vertigo—Cyclosporine—focal segmental glomerulosclerosis	0.00177	0.00535	CcSEcCtD
Doxepin—Leukopenia—Cyclosporine—focal segmental glomerulosclerosis	0.00177	0.00533	CcSEcCtD
Doxepin—Cough—Cyclosporine—focal segmental glomerulosclerosis	0.00172	0.00519	CcSEcCtD
Doxepin—Convulsion—Cyclosporine—focal segmental glomerulosclerosis	0.00171	0.00516	CcSEcCtD
Doxepin—Hypertension—Cyclosporine—focal segmental glomerulosclerosis	0.0017	0.00514	CcSEcCtD
Doxepin—Arthralgia—Cyclosporine—focal segmental glomerulosclerosis	0.00168	0.00507	CcSEcCtD
Doxepin—Chest pain—Cyclosporine—focal segmental glomerulosclerosis	0.00168	0.00507	CcSEcCtD
Doxepin—Myalgia—Cyclosporine—focal segmental glomerulosclerosis	0.00168	0.00507	CcSEcCtD
Doxepin—Anxiety—Cyclosporine—focal segmental glomerulosclerosis	0.00167	0.00505	CcSEcCtD
Doxepin—Unspecified disorder of skin and subcutaneous tissue—Cyclosporine—focal segmental glomerulosclerosis	0.00167	0.00503	CcSEcCtD
Doxepin—Discomfort—Cyclosporine—focal segmental glomerulosclerosis	0.00166	0.005	CcSEcCtD
Doxepin—Dry mouth—Cyclosporine—focal segmental glomerulosclerosis	0.00164	0.00495	CcSEcCtD
Doxepin—Confusional state—Cyclosporine—focal segmental glomerulosclerosis	0.00162	0.0049	CcSEcCtD
Doxepin—Oedema—Cyclosporine—focal segmental glomerulosclerosis	0.00161	0.00486	CcSEcCtD
Doxepin—Infection—Cyclosporine—focal segmental glomerulosclerosis	0.0016	0.00482	CcSEcCtD
Doxepin—Nervous system disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00158	0.00476	CcSEcCtD
Doxepin—Thrombocytopenia—Cyclosporine—focal segmental glomerulosclerosis	0.00158	0.00475	CcSEcCtD
Doxepin—Skin disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00156	0.00472	CcSEcCtD
Doxepin—Hyperhidrosis—Cyclosporine—focal segmental glomerulosclerosis	0.00156	0.00469	CcSEcCtD
Doxepin—Anorexia—Cyclosporine—focal segmental glomerulosclerosis	0.00153	0.00463	CcSEcCtD
Doxepin—Musculoskeletal discomfort—Cyclosporine—focal segmental glomerulosclerosis	0.00147	0.00442	CcSEcCtD
Doxepin—Insomnia—Cyclosporine—focal segmental glomerulosclerosis	0.00146	0.00439	CcSEcCtD
Doxepin—Paraesthesia—Cyclosporine—focal segmental glomerulosclerosis	0.00145	0.00436	CcSEcCtD
Doxepin—Dyspnoea—Cyclosporine—focal segmental glomerulosclerosis	0.00144	0.00433	CcSEcCtD
Doxepin—Somnolence—Cyclosporine—focal segmental glomerulosclerosis	0.00143	0.00432	CcSEcCtD
Doxepin—Dyspepsia—Cyclosporine—focal segmental glomerulosclerosis	0.00142	0.00427	CcSEcCtD
Doxepin—Decreased appetite—Cyclosporine—focal segmental glomerulosclerosis	0.0014	0.00422	CcSEcCtD
Doxepin—Gastrointestinal disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00139	0.00419	CcSEcCtD
Doxepin—Fatigue—Cyclosporine—focal segmental glomerulosclerosis	0.00139	0.00419	CcSEcCtD
Doxepin—Constipation—Cyclosporine—focal segmental glomerulosclerosis	0.00138	0.00415	CcSEcCtD
Doxepin—Pain—Cyclosporine—focal segmental glomerulosclerosis	0.00138	0.00415	CcSEcCtD
Doxepin—Feeling abnormal—Cyclosporine—focal segmental glomerulosclerosis	0.00133	0.004	CcSEcCtD
Doxepin—Gastrointestinal pain—Cyclosporine—focal segmental glomerulosclerosis	0.00132	0.00397	CcSEcCtD
Doxepin—Urticaria—Cyclosporine—focal segmental glomerulosclerosis	0.00128	0.00386	CcSEcCtD
Doxepin—Abdominal pain—Cyclosporine—focal segmental glomerulosclerosis	0.00127	0.00384	CcSEcCtD
Doxepin—Body temperature increased—Cyclosporine—focal segmental glomerulosclerosis	0.00127	0.00384	CcSEcCtD
Doxepin—Hypersensitivity—Cyclosporine—focal segmental glomerulosclerosis	0.00119	0.00358	CcSEcCtD
Doxepin—Asthenia—Cyclosporine—focal segmental glomerulosclerosis	0.00116	0.00348	CcSEcCtD
Doxepin—Pruritus—Cyclosporine—focal segmental glomerulosclerosis	0.00114	0.00344	CcSEcCtD
Doxepin—Diarrhoea—Cyclosporine—focal segmental glomerulosclerosis	0.0011	0.00332	CcSEcCtD
Doxepin—Dizziness—Cyclosporine—focal segmental glomerulosclerosis	0.00106	0.00321	CcSEcCtD
Doxepin—Vomiting—Cyclosporine—focal segmental glomerulosclerosis	0.00102	0.00309	CcSEcCtD
Doxepin—Rash—Cyclosporine—focal segmental glomerulosclerosis	0.00102	0.00306	CcSEcCtD
Doxepin—Dermatitis—Cyclosporine—focal segmental glomerulosclerosis	0.00101	0.00306	CcSEcCtD
Doxepin—Headache—Cyclosporine—focal segmental glomerulosclerosis	0.00101	0.00304	CcSEcCtD
Doxepin—Nausea—Cyclosporine—focal segmental glomerulosclerosis	0.000957	0.00288	CcSEcCtD
Doxepin—Oxcarbazepine—ALB—focal segmental glomerulosclerosis	0.000569	0.307	CrCbGaD
Doxepin—Thiothixene—ALB—focal segmental glomerulosclerosis	0.000413	0.223	CrCbGaD
Doxepin—Clomipramine—ALB—focal segmental glomerulosclerosis	0.000327	0.177	CrCbGaD
Doxepin—Nortriptyline—ALB—focal segmental glomerulosclerosis	0.000319	0.173	CrCbGaD
Doxepin—Amitriptyline—ALB—focal segmental glomerulosclerosis	0.000221	0.12	CrCbGaD
Doxepin—CHRM1—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	6.51e-05	0.000311	CbGpPWpGaD
Doxepin—ADRA2A—Metabolism—CTGF—focal segmental glomerulosclerosis	6.5e-05	0.000311	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	6.49e-05	0.00031	CbGpPWpGaD
Doxepin—CHRM2—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	6.48e-05	0.00031	CbGpPWpGaD
Doxepin—HTR6—Signaling Pathways—LPL—focal segmental glomerulosclerosis	6.47e-05	0.00031	CbGpPWpGaD
Doxepin—ADRA1A—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	6.47e-05	0.000309	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	6.46e-05	0.000309	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	6.45e-05	0.000308	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	6.43e-05	0.000307	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	6.41e-05	0.000307	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	6.37e-05	0.000305	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	6.34e-05	0.000303	CbGpPWpGaD
Doxepin—CHRM4—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	6.3e-05	0.000301	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	6.16e-05	0.000295	CbGpPWpGaD
Doxepin—HTR6—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	6.13e-05	0.000293	CbGpPWpGaD
Doxepin—CYP2C19—Metabolism of lipids and lipoproteins—AGT—focal segmental glomerulosclerosis	6.13e-05	0.000293	CbGpPWpGaD
Doxepin—CHRM4—Signaling Pathways—LPL—focal segmental glomerulosclerosis	6.11e-05	0.000292	CbGpPWpGaD
Doxepin—DRD2—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	6.09e-05	0.000291	CbGpPWpGaD
Doxepin—HTR2B—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	6.09e-05	0.000291	CbGpPWpGaD
Doxepin—ADRA2B—Hemostasis—TGFB1—focal segmental glomerulosclerosis	6.08e-05	0.000291	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	6.07e-05	0.00029	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	6.04e-05	0.000289	CbGpPWpGaD
Doxepin—CHRM5—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	6.03e-05	0.000288	CbGpPWpGaD
Doxepin—ADRA2A—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	6.01e-05	0.000287	CbGpPWpGaD
Doxepin—HTR2A—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	6e-05	0.000287	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	5.99e-05	0.000286	CbGpPWpGaD
Doxepin—ADRA2A—Metabolism—GNAQ—focal segmental glomerulosclerosis	5.99e-05	0.000286	CbGpPWpGaD
Doxepin—HRH1—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	5.98e-05	0.000286	CbGpPWpGaD
Doxepin—CHRM1—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	5.96e-05	0.000285	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	5.96e-05	0.000285	CbGpPWpGaD
Doxepin—CHRM3—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	5.95e-05	0.000284	CbGpPWpGaD
Doxepin—HTR2B—Signaling Pathways—LPL—focal segmental glomerulosclerosis	5.91e-05	0.000283	CbGpPWpGaD
Doxepin—CHRM2—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	5.89e-05	0.000282	CbGpPWpGaD
Doxepin—ADRA1A—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	5.87e-05	0.000281	CbGpPWpGaD
Doxepin—CHRM5—Signaling Pathways—LPL—focal segmental glomerulosclerosis	5.85e-05	0.00028	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	5.83e-05	0.000279	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	5.8e-05	0.000277	CbGpPWpGaD
Doxepin—CHRM4—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	5.78e-05	0.000277	CbGpPWpGaD
Doxepin—ADRA2C—Hemostasis—TGFB1—focal segmental glomerulosclerosis	5.68e-05	0.000272	CbGpPWpGaD
Doxepin—ADRA1D—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	5.67e-05	0.000271	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	5.64e-05	0.00027	CbGpPWpGaD
Doxepin—HTR2B—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	5.6e-05	0.000268	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	5.59e-05	0.000267	CbGpPWpGaD
Doxepin—CYP2C9—Metabolism of lipids and lipoproteins—AGT—focal segmental glomerulosclerosis	5.59e-05	0.000267	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism of lipids and lipoproteins—LPL—focal segmental glomerulosclerosis	5.58e-05	0.000267	CbGpPWpGaD
Doxepin—HRH2—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	5.55e-05	0.000266	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	5.55e-05	0.000265	CbGpPWpGaD
Doxepin—ADRA2C—Metabolism—LPL—focal segmental glomerulosclerosis	5.55e-05	0.000265	CbGpPWpGaD
Doxepin—CHRM5—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	5.54e-05	0.000265	CbGpPWpGaD
Doxepin—HTR6—Signaling Pathways—AGT—focal segmental glomerulosclerosis	5.54e-05	0.000265	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	5.5e-05	0.000263	CbGpPWpGaD
Doxepin—ADRA1D—Signaling Pathways—LPL—focal segmental glomerulosclerosis	5.5e-05	0.000263	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	5.49e-05	0.000263	CbGpPWpGaD
Doxepin—HRH4—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	5.49e-05	0.000262	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	5.47e-05	0.000262	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	5.46e-05	0.000261	CbGpPWpGaD
Doxepin—ADRA2A—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	5.46e-05	0.000261	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	5.4e-05	0.000258	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	5.39e-05	0.000258	CbGpPWpGaD
Doxepin—CYP2C19—Metabolism—LIPC—focal segmental glomerulosclerosis	5.23e-05	0.00025	CbGpPWpGaD
Doxepin—CHRM4—Signaling Pathways—AGT—focal segmental glomerulosclerosis	5.23e-05	0.00025	CbGpPWpGaD
Doxepin—ADRA1D—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	5.21e-05	0.000249	CbGpPWpGaD
Doxepin—HTR6—Signaling Pathways—FN1—focal segmental glomerulosclerosis	5.12e-05	0.000245	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	5.12e-05	0.000245	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	5.12e-05	0.000245	CbGpPWpGaD
Doxepin—ABCB1—Metabolism—LIPC—focal segmental glomerulosclerosis	5.1e-05	0.000244	CbGpPWpGaD
Doxepin—HTR2B—Signaling Pathways—AGT—focal segmental glomerulosclerosis	5.06e-05	0.000242	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	5.03e-05	0.000241	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	5.02e-05	0.00024	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	5.01e-05	0.000239	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	5.01e-05	0.000239	CbGpPWpGaD
Doxepin—CHRM5—Signaling Pathways—AGT—focal segmental glomerulosclerosis	5e-05	0.000239	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	4.99e-05	0.000239	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—LPL—focal segmental glomerulosclerosis	4.96e-05	0.000237	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	4.94e-05	0.000236	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	4.94e-05	0.000236	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	4.93e-05	0.000236	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	4.91e-05	0.000235	CbGpPWpGaD
Doxepin—CHRM3—Metabolism—LPL—focal segmental glomerulosclerosis	4.91e-05	0.000235	CbGpPWpGaD
Doxepin—CHRM4—Signaling Pathways—FN1—focal segmental glomerulosclerosis	4.83e-05	0.000231	CbGpPWpGaD
Doxepin—CYP2D6—Metabolism—LIPC—focal segmental glomerulosclerosis	4.81e-05	0.00023	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—LPL—focal segmental glomerulosclerosis	4.79e-05	0.000229	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	4.78e-05	0.000229	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism of lipids and lipoproteins—AGT—focal segmental glomerulosclerosis	4.78e-05	0.000228	CbGpPWpGaD
Doxepin—CYP2C9—Metabolism—LIPC—focal segmental glomerulosclerosis	4.77e-05	0.000228	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—LPL—focal segmental glomerulosclerosis	4.77e-05	0.000228	CbGpPWpGaD
Doxepin—ADRA2C—Metabolism—AGT—focal segmental glomerulosclerosis	4.74e-05	0.000227	CbGpPWpGaD
Doxepin—CYP2C19—Metabolism of lipids and lipoproteins—ALB—focal segmental glomerulosclerosis	4.7e-05	0.000225	CbGpPWpGaD
Doxepin—ADRA1D—Signaling Pathways—AGT—focal segmental glomerulosclerosis	4.7e-05	0.000225	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	4.7e-05	0.000225	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	4.7e-05	0.000225	CbGpPWpGaD
Doxepin—HTR2B—Signaling Pathways—FN1—focal segmental glomerulosclerosis	4.67e-05	0.000223	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—LPL—focal segmental glomerulosclerosis	4.64e-05	0.000222	CbGpPWpGaD
Doxepin—CHRM5—Signaling Pathways—FN1—focal segmental glomerulosclerosis	4.62e-05	0.000221	CbGpPWpGaD
Doxepin—ADRA2A—Hemostasis—TGFB1—focal segmental glomerulosclerosis	4.61e-05	0.000221	CbGpPWpGaD
Doxepin—CYP2C19—Metabolism—CTGF—focal segmental glomerulosclerosis	4.6e-05	0.00022	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	4.58e-05	0.000219	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—LPL—focal segmental glomerulosclerosis	4.56e-05	0.000218	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	4.54e-05	0.000217	CbGpPWpGaD
Doxepin—HRH4—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	4.52e-05	0.000216	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	4.52e-05	0.000216	CbGpPWpGaD
Doxepin—ADRA2A—Metabolism—LPL—focal segmental glomerulosclerosis	4.51e-05	0.000215	CbGpPWpGaD
Doxepin—ABCB1—Metabolism—CTGF—focal segmental glomerulosclerosis	4.49e-05	0.000215	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	4.39e-05	0.00021	CbGpPWpGaD
Doxepin—ABCB1—Transmembrane transport of small molecules—ALB—focal segmental glomerulosclerosis	4.37e-05	0.000209	CbGpPWpGaD
Doxepin—ADRA1D—Signaling Pathways—FN1—focal segmental glomerulosclerosis	4.35e-05	0.000208	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	4.34e-05	0.000207	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	4.32e-05	0.000207	CbGpPWpGaD
Doxepin—CYP2C9—Metabolism of lipids and lipoproteins—ALB—focal segmental glomerulosclerosis	4.29e-05	0.000205	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	4.27e-05	0.000204	CbGpPWpGaD
Doxepin—HTR6—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	4.26e-05	0.000204	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	4.26e-05	0.000204	CbGpPWpGaD
Doxepin—HRH2—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	4.25e-05	0.000203	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—AGT—focal segmental glomerulosclerosis	4.25e-05	0.000203	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	4.24e-05	0.000203	CbGpPWpGaD
Doxepin—CYP2C19—Metabolism—GNAQ—focal segmental glomerulosclerosis	4.24e-05	0.000203	CbGpPWpGaD
Doxepin—CYP2D6—Metabolism—CTGF—focal segmental glomerulosclerosis	4.24e-05	0.000203	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	4.23e-05	0.000202	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—LPL—focal segmental glomerulosclerosis	4.21e-05	0.000201	CbGpPWpGaD
Doxepin—CHRM3—Metabolism—AGT—focal segmental glomerulosclerosis	4.2e-05	0.000201	CbGpPWpGaD
Doxepin—CYP2C9—Metabolism—CTGF—focal segmental glomerulosclerosis	4.2e-05	0.000201	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	4.19e-05	0.0002	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	4.18e-05	0.0002	CbGpPWpGaD
Doxepin—ABCB1—Metabolism—GNAQ—focal segmental glomerulosclerosis	4.14e-05	0.000198	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—LPL—focal segmental glomerulosclerosis	4.14e-05	0.000198	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—LPL—focal segmental glomerulosclerosis	4.13e-05	0.000198	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—LPL—focal segmental glomerulosclerosis	4.12e-05	0.000197	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—LPL—focal segmental glomerulosclerosis	4.11e-05	0.000196	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—AGT—focal segmental glomerulosclerosis	4.1e-05	0.000196	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—AGT—focal segmental glomerulosclerosis	4.08e-05	0.000195	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism—LIPC—focal segmental glomerulosclerosis	4.08e-05	0.000195	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—LPL—focal segmental glomerulosclerosis	4.07e-05	0.000194	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—LPL—focal segmental glomerulosclerosis	4.05e-05	0.000194	CbGpPWpGaD
Doxepin—CHRM4—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	4.02e-05	0.000192	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	3.99e-05	0.000191	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—AGT—focal segmental glomerulosclerosis	3.97e-05	0.00019	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—FN1—focal segmental glomerulosclerosis	3.92e-05	0.000188	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	3.92e-05	0.000188	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	3.91e-05	0.000187	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—AGT—focal segmental glomerulosclerosis	3.9e-05	0.000187	CbGpPWpGaD
Doxepin—CYP2D6—Metabolism—GNAQ—focal segmental glomerulosclerosis	3.9e-05	0.000187	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	3.9e-05	0.000187	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	3.89e-05	0.000186	CbGpPWpGaD
Doxepin—HTR2B—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	3.89e-05	0.000186	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	3.88e-05	0.000186	CbGpPWpGaD
Doxepin—CYP2C9—Metabolism—GNAQ—focal segmental glomerulosclerosis	3.87e-05	0.000185	CbGpPWpGaD
Doxepin—ADRA2A—Metabolism—AGT—focal segmental glomerulosclerosis	3.85e-05	0.000184	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	3.85e-05	0.000184	CbGpPWpGaD
Doxepin—CHRM5—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	3.85e-05	0.000184	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	3.84e-05	0.000184	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—FN1—focal segmental glomerulosclerosis	3.79e-05	0.000181	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—FN1—focal segmental glomerulosclerosis	3.77e-05	0.00018	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—LPL—focal segmental glomerulosclerosis	3.77e-05	0.00018	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—FN1—focal segmental glomerulosclerosis	3.67e-05	0.000175	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism of lipids and lipoproteins—ALB—focal segmental glomerulosclerosis	3.67e-05	0.000175	CbGpPWpGaD
Doxepin—ADRA2C—Metabolism—ALB—focal segmental glomerulosclerosis	3.64e-05	0.000174	CbGpPWpGaD
Doxepin—ADRA1D—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	3.62e-05	0.000173	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—FN1—focal segmental glomerulosclerosis	3.61e-05	0.000173	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—AGT—focal segmental glomerulosclerosis	3.6e-05	0.000172	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism—CTGF—focal segmental glomerulosclerosis	3.59e-05	0.000172	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	3.57e-05	0.000171	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—AGT—focal segmental glomerulosclerosis	3.54e-05	0.000169	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—AGT—focal segmental glomerulosclerosis	3.53e-05	0.000169	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—AGT—focal segmental glomerulosclerosis	3.52e-05	0.000168	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—AGT—focal segmental glomerulosclerosis	3.51e-05	0.000168	CbGpPWpGaD
Doxepin—HRH2—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	3.51e-05	0.000168	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—AGT—focal segmental glomerulosclerosis	3.48e-05	0.000166	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—AGT—focal segmental glomerulosclerosis	3.47e-05	0.000166	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—FN1—focal segmental glomerulosclerosis	3.33e-05	0.000159	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism—GNAQ—focal segmental glomerulosclerosis	3.31e-05	0.000158	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—FN1—focal segmental glomerulosclerosis	3.27e-05	0.000157	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—FN1—focal segmental glomerulosclerosis	3.27e-05	0.000156	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	3.27e-05	0.000156	CbGpPWpGaD
Doxepin—HTR6—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	3.26e-05	0.000156	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—FN1—focal segmental glomerulosclerosis	3.26e-05	0.000156	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—FN1—focal segmental glomerulosclerosis	3.25e-05	0.000155	CbGpPWpGaD
Doxepin—CHRM3—Metabolism—ALB—focal segmental glomerulosclerosis	3.22e-05	0.000154	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—AGT—focal segmental glomerulosclerosis	3.22e-05	0.000154	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—FN1—focal segmental glomerulosclerosis	3.21e-05	0.000154	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—FN1—focal segmental glomerulosclerosis	3.2e-05	0.000153	CbGpPWpGaD
Doxepin—CYP2C19—Metabolism—LPL—focal segmental glomerulosclerosis	3.19e-05	0.000153	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	3.15e-05	0.000151	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—LIPC—focal segmental glomerulosclerosis	3.15e-05	0.00015	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	3.14e-05	0.00015	CbGpPWpGaD
Doxepin—ABCB1—Metabolism—LPL—focal segmental glomerulosclerosis	3.12e-05	0.000149	CbGpPWpGaD
Doxepin—CHRM4—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	3.08e-05	0.000147	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	3.05e-05	0.000146	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	3e-05	0.000144	CbGpPWpGaD
Doxepin—HTR2B—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	2.98e-05	0.000142	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—FN1—focal segmental glomerulosclerosis	2.98e-05	0.000142	CbGpPWpGaD
Doxepin—ADRA2A—Metabolism—ALB—focal segmental glomerulosclerosis	2.96e-05	0.000141	CbGpPWpGaD
Doxepin—CHRM5—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	2.95e-05	0.000141	CbGpPWpGaD
Doxepin—CYP2D6—Metabolism—LPL—focal segmental glomerulosclerosis	2.94e-05	0.00014	CbGpPWpGaD
Doxepin—CYP2C9—Metabolism—LPL—focal segmental glomerulosclerosis	2.91e-05	0.000139	CbGpPWpGaD
Doxepin—ADRA1D—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	2.77e-05	0.000133	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—CTGF—focal segmental glomerulosclerosis	2.77e-05	0.000132	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	2.77e-05	0.000132	CbGpPWpGaD
Doxepin—CYP2C19—Metabolism—AGT—focal segmental glomerulosclerosis	2.73e-05	0.000131	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	2.72e-05	0.00013	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	2.72e-05	0.00013	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	2.71e-05	0.00013	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	2.7e-05	0.000129	CbGpPWpGaD
Doxepin—HTR6—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	2.69e-05	0.000129	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	2.67e-05	0.000128	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	2.67e-05	0.000128	CbGpPWpGaD
Doxepin—ABCB1—Metabolism—AGT—focal segmental glomerulosclerosis	2.67e-05	0.000127	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—GNAQ—focal segmental glomerulosclerosis	2.55e-05	0.000122	CbGpPWpGaD
Doxepin—CHRM4—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	2.54e-05	0.000121	CbGpPWpGaD
Doxepin—CYP2D6—Metabolism—AGT—focal segmental glomerulosclerosis	2.51e-05	0.00012	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	2.5e-05	0.00012	CbGpPWpGaD
Doxepin—CYP2C9—Metabolism—AGT—focal segmental glomerulosclerosis	2.49e-05	0.000119	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism—LPL—focal segmental glomerulosclerosis	2.49e-05	0.000119	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	2.48e-05	0.000118	CbGpPWpGaD
Doxepin—HTR2B—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	2.45e-05	0.000117	CbGpPWpGaD
Doxepin—CHRM5—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	2.43e-05	0.000116	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	2.41e-05	0.000115	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	2.4e-05	0.000115	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	2.34e-05	0.000112	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	2.3e-05	0.00011	CbGpPWpGaD
Doxepin—ADRA1D—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	2.28e-05	0.000109	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism—AGT—focal segmental glomerulosclerosis	2.13e-05	0.000102	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	2.12e-05	0.000101	CbGpPWpGaD
Doxepin—CYP2C19—Metabolism—ALB—focal segmental glomerulosclerosis	2.1e-05	0.0001	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	2.09e-05	9.98e-05	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	2.08e-05	9.95e-05	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	2.07e-05	9.92e-05	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	2.07e-05	9.89e-05	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	2.06e-05	9.86e-05	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	2.05e-05	9.8e-05	CbGpPWpGaD
Doxepin—ABCB1—Metabolism—ALB—focal segmental glomerulosclerosis	2.05e-05	9.78e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	2.04e-05	9.77e-05	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	1.99e-05	9.52e-05	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	1.98e-05	9.47e-05	CbGpPWpGaD
Doxepin—CYP2D6—Metabolism—ALB—focal segmental glomerulosclerosis	1.93e-05	9.22e-05	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	1.93e-05	9.21e-05	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—LPL—focal segmental glomerulosclerosis	1.92e-05	9.18e-05	CbGpPWpGaD
Doxepin—CYP2C9—Metabolism—ALB—focal segmental glomerulosclerosis	1.91e-05	9.14e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	1.9e-05	9.08e-05	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	1.9e-05	9.06e-05	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	1.75e-05	8.36e-05	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	1.72e-05	8.22e-05	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	1.72e-05	8.2e-05	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	1.71e-05	8.18e-05	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	1.7e-05	8.15e-05	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	1.69e-05	8.07e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	1.68e-05	8.05e-05	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—AGT—focal segmental glomerulosclerosis	1.64e-05	7.85e-05	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism—ALB—focal segmental glomerulosclerosis	1.63e-05	7.81e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	1.56e-05	7.48e-05	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—ALB—focal segmental glomerulosclerosis	1.26e-05	6.03e-05	CbGpPWpGaD
